Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/25
End: 11/01/39
Due: 11/01/40
Phase: N/A
Priority: Normal
Start: 01/22/24
End: 01/15/33
Due: 01/15/34
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| BRAZAN Trial in Frontline MCL | NCT06854003 | Christine Ryan | user2@example.com | None | 2025-08-31 | 2039-11-01 | 2040-11-01 | - | - | 2025-07-14 |
| A Ph2 Study of Glofitamab Alone or With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation | NCT06043674 | Christine Ryan | user2@example.com | None | 2024-01-22 | 2033-01-15 | 2034-01-15 | - | - | 2025-07-14 |